Psoriasis Vulgaris Information

Learn about this condition, its impact, and our breakthrough treatment approach

Begin Assessment

WHAT IS PSORIASIS

  • Psoriasis is a chronic, non-communicable, painful, disfiguring, and disabling disease, caused by a dysfunction of the immune system. There is no cure, and it has a great negative impact on patients' quality of life.
  • It can occur at any age and is most common in the age groups between 50–69.
  • In addition to suffering from the disease's typical manifestations, people living with psoriasis have an increased risk of co-morbidities, like diabetes and cardiovascular disease. The impact on mental health can also be significant.
  • Psoriasis causes great physical, emotional, social, and financial burdens.

PREVALENCE

  • Statistics are unreliable, insufficient, and often based on patients seeking medical health.
  • Psoriasis affects men and women of all ages, regardless of ethnic origin, in all countries.
  • Published data on the prevalence of psoriasis in countries vary between 0.09% and 11.4%.
  • The highest prevalence of Psoriasis is in the North European countries and Russia where close to 12% of the general population is affected by this disease.
  • In China, the prevalence of Psoriasis Vulgaris is above 0.5% of the general population.
  • In 2019, China had the largest prevalence cases 7.65 million, followed by India with 4.8 million.
  • There is also evidence to suggest that the prevalence of psoriasis may be increasing.
  • Qatar and the United Arab Emirates had the highest increase in the prevalence of Psoriasis with a growth rate of 455% and 381% respectively over the period between 1990 and 2019. China experienced a change rate of 21% during the same period.

TYPES OF PSORIASIS

Psoriasis Vulgaris (or Plaque Psoriasis)

Psoriasis Vulgaris

Affects between 80% and 90% of all Psoriasis types. It commonly affects the scalp, elbows, knees, face, lower back, soles of the feet, and palms of the hands.

Guttate Psoriasis

Guttate Psoriasis

Affects up to 8% of all people with psoriasis. It often begins in childhood or early adulthood, and the lesions it causes are small and numerous.

Inverse psoriasis

Inverse Psoriasis

Inverse psoriasis affects between 3% and 7% of all people with psoriasis and can play a role in genital psoriasis.

Pustular psoriasis

Pustular Psoriasis

This is a rare and severe form of psoriasis that involves widespread inflammation of the skin. It appears as small white or yellow pus-filled blisters or pustules.

Nail psoriasis

Nail Psoriasis

Can occur with any type of psoriasis but is most common with plaque psoriasis. Around 50-80% of those with nail psoriasis have psoriatic arthritis. Some medications may increase the person's risk of developing fungal infections. It is possible to have both a fungal infection and nail psoriasis at the same time.

Erythrodermic psoriasis

Erythrodermic Psoriasis

Erythrodermic psoriasis is rare, aggressive, and can be life-threatening (mortality rate is between 10% and 65%. It reduces the skin's ability to protect the body. It causes itching, dehydration, an increased heart rate, shivering, and sudden changes in body temperature. There is a high chance of developing pneumonia or sepsis.

COMORBIDITIES

  1. Psoriatic Arthritis: Around 1/3 of Psoriasis patients develop psoriatic arthritis (PsA), a chronic inflammatory disease that causes stiffness and pain in joints.
  2. Mental Health Disorders: People with psoriasis are 1.5 times more likely to experience depression, and have 20% to 50% greater risk of anxiety, compared to those without this condition. Children and teens who have psoriasis or psoriatic disease are at a higher risk of developing these mental health complications. While psoriasis can lead to depression, there's also evidence that a reverse dynamic is in play as well, depression can make psoriasis worse. These two conditions amplify each other.
  3. Metabolic Syndrome: According to a review, an estimated 20 to 50 percent of people with psoriasis are affected by metabolic syndrome, and the risk of having this health issue increases with the severity of psoriasis. Metabolic syndrome is characterized by high blood pressure, weight gain, elevated blood sugar levels due to insulin resistance, and elevated blood fat. Combined, these factors increase your risk of coronary heart disease, stroke, diabetes, and other serious health problems.
  4. Heart Disease: People with psoriasis are at an increased risk of cardiovascular disease. That risk can increase further if you have additional common risk factors, such as high blood pressure, high low-density lipoprotein, and obesity. So, if you have psoriasis, you should consider a cardiovascular disease prevention strategy as part of your psoriasis treatment and management.

COMORBIDITIES IN CHINA

A study published in 2022 has shown that Psoriasis patients in China have a positive linear relationship with mental disorders, Hodgkin lymphoma, leukemia, rheumatic heart disease, chronic obstructive pulmonary disease, and asthma for Psoriasis patients in China.

However, in China, the females had different associations of psoriasis with the above diseases compared to males.

In males, a positive linear relationship was seen with nonmelanoma skin cancer, non-Hodgkin lymphoma, multiple myeloma, ischemic heart disease, cardiomyopathy, myocarditis, nonrheumatic valvular heart disease, multiple sclerosis, diabetes mellitus, and rheumatoid arthritis.

For females, a strong positive relationship was seen in chronic obstructive pulmonary disease, asthma, cirrhosis, other chronic liver diseases, and inflammatory bowel disease.

In short, a positive linear relationship between psoriasis prevalence and comorbidities was seen with different diseases in China within the male and female groups.

STANDARD TREATMENT

  • The first rule in medicine (or the Hippocratic Oath) – DO NOT HARM.
  • The standard treatment of psoriasis is still based on controlling the symptoms. The need for treatment is usually lifelong and is aimed at remission. So far, a therapy that would give hope for a complete cure for psoriasis does not exist. Additionally, care for patients with psoriasis requires not only treating skin lesions and joint involvement but also the comorbidities that already exist or may develop, including cardiovascular and metabolic diseases, and psychological conditions.
  • Corticosteroids – are the most frequently prescribed medications for mild to moderate psoriasis. They are available as oils, ointments, creams, lotions, gels, foams, sprays, and shampoos.
  • Mode of action. Corticosteroids are immunosuppressants- they reduce inflammation by reducing the strength of the body's immune system.
  • Side Effects. With long-term use, corticosteroids can result in many side effects, including a need for increased doses to manage physical stress, steroid withdrawal syndrome, insomnia, mood changes, elevated blood pressure or blood sugar levels, infections, gastrointestinal symptoms, subsequent weight gain, osteoporosis, cataracts or glaucoma in the eyes, hardening of the arteries or avascular necrosis.
  • Steroid Withdrawal Syndrome ("SWS") is a side effect of stopping topical steroids. Most people do not experience problems while taking the medications, however, stopping the medications can cause rebound symptoms such as burning, redness, and itchy skin.
    • SWS develops between 2 days and 2 weeks from stopping the medications.
    • Symptoms of the SWS are often worse than the skin condition for which you were taking the steroid treatment.
    • Steroid Withdrawal Syndrome can last anywhere from a couple of months to many years. Topical steroid withdrawal can have a huge effect on people's lives. These severe symptoms can significantly impact one's work and social life.
  • Is this DO NOT HARM?

OUR RESULTS

General definition of a "Cure": A cure is when a treatment makes a health problem go away and it's not expected to come back. Some health problems have a cure. For example, to treat athlete's foot, healthcare providers use special creams, powders, or sprays that kill the fungus that causes the infection.

Our definition of a "Cure": A cure is when a treatment makes a health problem go away and is not expected to come back, there are no symptoms for a minimum period of one (1) year, no medications are used during this period, and the person lives a normal life.

The official answer of the medical industry – there is no cure for Psoriasis, but you can take steps to manage the disease.

Our answer: Based on the above definition of a cure, all 300 plus Psoriasis Vulgaris clients we have treated in the past 10 years (since 2013) have been cured, and the disease has not returned up until now (October 2024). The worst case was a client who experienced a tiny dot on her hand after going through severe family trauma caused by the loss of her child 6 years after receiving treatment. The follow-up protocol was repeated, and the patient completely recovered after 2 weeks and has been free of any Psoriasis disease since. To the best of our knowledge, we are not aware of other relapses in our clients.

Our success rate in eradicating Psoriasis Vulgaris since 2013 is close to 100%. This figure does not include patients who have been found to have allergic reactions to our products or have not completed the protocol.

Exceptions:

  • We do not accept clients with Psoriasis lesions on the palms of their hands or the soles of their feet because our products and services are unable to remove the psoriasis plaque in these areas.
  • We only accept clients suffering from psoriasis vulgaris. This is because we have never tried eradicating other types of psoriasis. More research is needed in this area.
  • We typically do not accept clients suffering from Steroid Withdrawal Syndrome.

APPLICATION & USE

Application: oral, topical, and minor dietary restrictions.

Side Effects: None that we know or have experienced in the past.

Interruption of lifestyle: None.

Duration of Use: 3 months.

Removal of psoriasis plaque & return of healthy skin: A complete removal of the psoriasis plaque typically occurs within the first 2 or 3 weeks. Return to normal life is typically achieved within the first 60 days.

Warnings:

  • We only accept clients suffering from Psoriasis Vulgaris. We do not know if our products and services can eradicate other types of Psoriasis because we have never attempted doing this. More research is needed in this area.
  • Not suitable for pregnant women, kids under 12, people with allergies, people with plaque on the palms of the hands or the soles of the feet, and people suffering from Steroid Withdrawal Syndrome.
  • Always test for allergies before starting our protocol by applying a few drops of the topical products on the forearms, where the skin is healthy, and without psoriasis lesions. If after 12 hours there is no allergic reaction on the skin (redness or blisters), you can start with our protocol, alternatively, the use of the products and services must be immediately discontinued.
  • You must not use perfumes or deodorants for the entire duration of the protocol.
  • You are not allowed to drink alcohol and carbonated drinks for the entire duration of the protocol. Drink water.

Method of Action:

Unlike traditional medication, the products used in our protocol do not include or contain immunosuppressants and do not lower the immune system. On the contrary, our products and services typically promote and improve the immune system while eliminating the root causes that promote the proliferation of the keratinocytes causing psoriasis lesions.

Side effects:

  • Our products may cause mild itching, typically in the first few days of the protocol.
  • To the best of our knowledge, we are not aware of any other side effects.

Other products and medications:

  • The products described in this presentation are the only products used during our protocol.
  • No other products, medications, or practices are allowed for the entire duration of our protocol. If the patient is taking other medications or products, these must be immediately discontinued before the commencement of our protocol.

Home Use:

  • Our protocol is suitable for home use and does not require medical intervention. The products described in this presentation are the only products used during our treatment.

Not a medical treatment:

This treatment is not a medical treatment. The statements in this document have not been evaluated by the FDA or CFDA.

ASSESSMENT & ACCEPTANCE

Assessment procedure:

  • Complete the Psoriasis Vulgaris Assessment Form.
  • Provide a history of the disease.
  • Provide Pictures of all patches of skin affected by Psoriasis Vulgaris on your body.
  • Provide official diagnostics from your doctor.

Acceptance:

  • After you complete the Psoriasis Vulgaris Assessment Form and the other required documents, our team will contact you within 48 hours to inform you of the outcome of your acceptance.
  • You are entitled to a free consultation with our experts before deciding to proceed with our protocol.
Begin Assessment Process

A CASE IN CHINA

This client had been suffering from psoriasis vulgaris for 20 years before contacting us. Over the course of 20 years, she tried all possible treatment options, including traditional Chinese medicine and biological therapy, but each time either the results were unsatisfactory or the condition quickly recurred, becoming increasingly severe. The affected area was large (over 90%), covering the whole body and scalp. The client is in treatment for 15 days only (as of October 17, 2021) and the pictures show the result of the treatment AFTER THE FIRST 15 DAYS.

Hand Comparison

Hand Before Treatment

Before

Hand After Treatment

After 15 days

Second Hand Comparison

Second Hand Before Treatment

Before

Second Hand After Treatment

After 15 days

Leg Comparison

Leg Before Treatment

Before

Leg After Treatment

After 15 days

Second Leg Comparison

Second Leg Before Treatment

Before

Second Leg After Treatment

After 15 days

Arm Comparison

Arm Before Treatment

Before

Arm After Treatment

After 15 days

Body Comparison

Body Before Treatment

Before

Body After Treatment

After 15 days

QUESTIONS & ANSWERS

1. Does this protocol work for all types of Psoriasis?

At this stage, we only accept clients with Psoriasis Vulgaris. At this stage, we have not tried our protocol on other types of psoriasis, and we do not know if our protocol is effective against other types of psoriasis. More research is needed to find more information on this topic.

2. How many clients have already used your services?

Over 300 clients in Europe have successfully used our products and services for eradication of Psoriasis Vulgaris (also known as Plaque Psoriasis).

3. What do you mean by cure?

Our definition of a cure means that the disease or the condition the patient suffers from has been completely removed and the disease or the condition does not come back for a minimum period of one (1) year.

4. Did you have cases where the treatment was unsuccessful?

Yes, we have had clients who were allergic to some of the ingredients used in our products. We immediately discontinue the use of the products and services for such clients.

All clients who have completed our protocol were successful in eradicating their Psoriasis Vulgaris lesions since 2013 until now (October 2024), we are not aware of any relapse except for one or several minor dots that have also been successfully removed with the follow-up protocol.

5. What are the Exclusion Criteria?

Our protocol is not suitable for pregnant women, kids under 12, people with allergies, people with plaque on the palms of the hands or the soles on the feet, and people suffering from Steroid Withdrawal Syndrome.

Take Assessment Now

REFERENCES

  • Global Report on Psoriasis 2016, World Health Organization.
  • The Local, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study, Frontiers in Medicine
  • National, regional, and worldwide epidemiology of psoriasis: a systematic analysis and modeling study, BMJ Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
  • Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030, Springer
  • Global Psoriasis Atlas Annual Report 2023-2024
  • The Burden of Psoriasis in China and Global Level from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019
  • Associations between psoriasis and mental illness: an update for clinicians, Science